Update Status An update to this guideline is in development (est. publication 12/2023), combined with an update to the Drug-Resistant Tuberculosis guideline. This update will be a joint effort with ...

Abstract Background Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent ...

We provide our members with research and educational opportunities. We help them stay up to date on news and developments in the field. We advocate for better ID funding and evidence-based policies ...

The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America have updated clinical practice guidelines for ...

Abstract These guidelines are intended for use by healthcare professionals who care for children and adults with suspected or confirmed infectious diarrhea. They are not intended to replace physician ...

This document presents guidelines for developing institutional programs to enhance antimicrobial stewardship, an activity that includes appropriate selection, dosing, route, and duration of ...

Antimicrobial stewardship is built around a simple principle: Give the right antibiotic, to the right patient, at the right dose, for the right duration. But what happens when the “right” antibiotic ...

The 2026 Antimicrobial Resistance Threats Report from the Centers for Disease Control and Prevention shows that drug-resistant bacteria and fungi result in nearly 10 million infections and over 50,000 ...

Expertise in clinical problem-solving defines and distinguishes infectious diseases as a specialty. A new, ongoing series of articles in Clinical Infectious Diseases — “Clinical Dilemmas in Infectious ...